Description
IMPLEMENTING EO 14398 DEI DISCRIMINATION
Base award description: NEW AWARD FOR FILGRASTIM-SNDZ PRE-FILLED SYRINGES WITH SANDOZ. PERIOD OF PERFORMANCE IS JUNE 30, 2022 TO JUNE 29, 2023 WITH FOUR ONE-YEAR OPTIONS
First action · last action
2022-02-18 · 2026-08-31
Transactions
17
First transaction's obligation
$0
Base + all options value (sum of deltas)
$17,471,465
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
3
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 17 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-02-18+$0= $0
- Mod P000012022-11-30+$0= $0
- Mod P000022022-12-20+$0= $0
- Mod P000032023-04-17+$0= $0
- Mod P000042023-05-03+$0= $0
- Mod P000052023-12-12+$0= $0
- Mod P000062024-02-01+$0= $0
- Mod P000072024-02-15+$0= $0
- Mod P000082024-02-22+$0= $0
- Mod P000092024-05-20+$0= $0
- Mod P000102024-11-25+$0= $0
- Mod P000112024-12-27+$0= $0
- Mod P000122025-05-08+$0= $0
- Mod P000132025-11-21+$0= $0
- Mod P000142026-01-12+$0= $0
- Mod P000152026-06-04+$0= $0
- Mod P000162026-08-31+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-02-18 | +$0 | $0 | NEW AWARD FOR FILGRASTIM-SNDZ PRE-FILLED SYRINGES WITH SANDOZ. PERIOD OF PERFORMANCE IS JUNE 30, 2022 TO JUNE… |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-11-30 | +$0 | $0 | 2023 PUBLIC LAW PRICING UPDATES |
| Mod P00002· ADD SUBCONTRACTING PLAN | 2022-12-20 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE SANDOZ INC. 2023 SUBCONTRACTING PLAN EFFECTIVE FOR THE PERIOD OF JA… |
| Mod P00003· OTHER ADMINISTRATIVE ACTION | 2023-04-17 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE THE DRUG SUPPLY SECURITY ACT (DSCSA) LANGUAGE INTO THE CONTRACT. |
| Mod P00004· EXERCISE AN OPTION | 2023-05-03 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO EXERCISE THE 1ST OPTION YEAR FOR FILGRASTIM PRE-FILLED SYRINGES UNDER CONTRACT… |
| Mod P00005· OTHER ADMINISTRATIVE ACTION | 2023-12-12 | +$0 | $0 | 2024 PUBLIC LAW PRICING UPDATES. NO CHANGES TO THE NATIONAL CONTRACT PRICES. |
| Mod P00006· ADD SUBCONTRACTING PLAN | 2024-02-01 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE SANDOZ INC. 2024 SUBCONTRACTING PLAN |
| Mod P00007· OTHER ADMINISTRATIVE ACTION | 2024-02-15 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE A CHANGE IN THE ADMINISTRATION AND SALES POINT OF CONTACT FOR SANDO… |
| Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-02-22 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO UPDATE THE TERMS OF THE CRF PAYMENT REMITTAL AND SUBMISSION OF QUARTERLY SALES… |
| Mod P00009· EXERCISE AN OPTION | 2024-05-20 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO EXERCISE OPTION YEAR 2 ON NC 36E79722D0016 WITH A PERIOD OF PERFORMANCE OF 06/3… |
| Mod P00010· OTHER ADMINISTRATIVE ACTION | 2024-11-25 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE 2025 FEDERAL CEILING PRICES UNDER CONTRACT 36E79722D0016. NO CHANGE… |
| Mod P00011· ADD SUBCONTRACTING PLAN | 2024-12-27 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE SANDOZ INC. 2025 SUBCONTRACTING PLAN EFFECTIVE FOR THE PERIOD OF JA… |
| Mod P00012· EXERCISE AN OPTION | 2025-05-08 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO EXERCISE THE 3RD OPTION YEAR FOR FILGRASTIM PRE-FILLED SYRINGES UNDER CONTRACT… |
| Mod P00013· OTHER ADMINISTRATIVE ACTION | 2025-11-21 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE 2026 FEDERAL CEILING PRICES UNDER CONTRACT 36E79722D0016 WITH SANDO… |
| Mod P00014· ADD SUBCONTRACTING PLAN | 2026-01-12 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE SANDOZ INC., 2026 SUBCONTRACTING PLAN INTO CONTRACT 36E79722D0016. |
| Mod P00015· EXERCISE AN OPTION | 2026-06-04 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO EXERCISE OPTION YEAR 4 FOR CONTRACT 36E79722D0016. |
| Mod P00016· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-08-31 | +$0 | $0 | IMPLEMENTING EO 14398 DEI DISCRIMINATION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ETJGHMFH1MT5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79723D0187 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36E79723D0005 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36E79723D0001 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36E79722D0033 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
| 36E79722D0011 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
| 36E79721D0010 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2021 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79722D0016_3600 · retrieved 2026-09-26.